Why Paralysis is Not Recommended for LMA Insertion
Routine use of neuromuscular blocking agents (paralysis) is not recommended for laryngeal mask airway (LMA) insertion because adequate insertion conditions are reliably achieved with appropriate doses of hypnotic agents alone, making paralysis unnecessary in most cases. 1
Primary Rationale
High success rates without paralysis: LMA insertion success rates are commonly high and ventilation conditions are often satisfactory when adequate doses of propofol (2.0-2.5 mg/kg) are used without neuromuscular blockade. 1
The 2020 Anaesthesia guidelines explicitly state: "Routine use of a muscle relaxant to facilitate insertion of a supraglottic device is probably not recommended (GRADE 2)." 1
When Paralysis May Be Beneficial
Despite the general recommendation against routine use, neuromuscular blockade has specific utility in certain scenarios:
Low-dose induction protocols: Paralysis becomes useful when doses of hypnotic and opioid agents used for induction are deliberately kept low. 1
Non-propofol anesthesia: Anesthesia protocols that exclude propofol as an induction agent have a high rate of adverse insertion events, and this incidence decreases with neuromuscular blockade. 1
Airway obstruction management: If airway obstruction or laryngospasm occurs after LMA placement, administration of a muscle relaxant is recommended (GRADE 2+). 1
The Critical Safety Concern
The fundamental issue with routine paralysis for LMA insertion relates to airway security:
Cannot intubate, cannot ventilate risk: Unlike endotracheal intubation where the airway is definitively secured, an LMA is a supraglottic device that does not protect against aspiration or guarantee ventilation in all patients. 1
Prolonged apnea without secured airway: Suxamethonium effects last 7-12 minutes with significant individual variability, and rocuronium without immediate sugammadex availability creates even longer paralysis duration. 1
Loss of rescue option: If LMA insertion fails or ventilation is inadequate after paralysis, you have eliminated the patient's ability to breathe spontaneously while lacking a definitive airway—a potentially catastrophic situation. 1
Clinical Algorithm for LMA Insertion
Standard approach:
- Induce with propofol 2.0-2.5 mg/kg ± opioid
- Attempt LMA insertion without paralysis
- Assess ventilation adequacy
If insertion difficult or ventilation inadequate:
- Deepen anesthesia with additional propofol (0.5-1.0 mg/kg)
- Optimize LMA position or change size
- Consider paralysis only if above measures fail AND you are confident in your ability to mask ventilate
Reserve paralysis for:
- Laryngospasm (suxamethonium 1.0 mg/kg is the agent of choice) 1
- Persistent glottic closure after adequate anesthetic depth 1
- Planned conversion to endotracheal intubation
Common Pitfalls to Avoid
Do not reflexively paralyze for LMA insertion as you would for endotracheal intubation—the risk-benefit calculation is fundamentally different. 1
Avoid inadequate propofol dosing: Using subtherapeutic propofol doses and compensating with paralysis creates unnecessary risk; proper hypnotic dosing usually eliminates the need for muscle relaxants. 1
Do not assume paralysis improves ventilation quality: No publications have reported adverse effects of neuromuscular blockade on ventilation quality with supraglottic devices, but this does not justify routine use when success rates are already high without it. 1